ALIM
Income statement / Annual
Last year (2023), Alimera Sciences, Inc.'s total revenue was $80.75 M,
an increase of 49.19% from the previous year.
In 2023, Alimera Sciences, Inc.'s net income was -$20.13 M.
See Alimera Sciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$80.75 M
|
$54.13 M
|
$59.03 M
|
$50.82 M
|
$53.94 M
|
$46.97 M
|
$35.91 M
|
$34.33 M
|
$22.44 M
|
$8.42 M
|
| Cost of Revenue |
$19.58 M |
$7.98 M |
$7.03 M |
$6.94 M |
$6.63 M |
$4.68 M |
$3.44 M |
$2.34 M |
$1.76 M |
$1.44 M |
| Gross Profit |
$61.17 M |
$46.15 M |
$52.00 M |
$43.88 M |
$47.32 M |
$42.29 M |
$32.47 M |
$31.99 M |
$20.68 M |
$6.98 M |
| Gross Profit Ratio |
0.76 |
0.85 |
0.88 |
0.86 |
0.88 |
0.9 |
0.9 |
0.93 |
0.92 |
0.83 |
| Research and Development
Expenses |
$16.63 M
|
$16.23 M
|
$13.78 M
|
$9.67 M
|
$10.99 M
|
$11.27 M
|
$12.84 M
|
$12.38 M
|
$14.84 M
|
$11.81 M
|
| General & Administrative
Expenses |
$18.53 M
|
$12.87 M
|
$12.77 M
|
$11.65 M
|
$13.95 M
|
$14.53 M
|
$13.04 M
|
$15.26 M
|
$14.19 M
|
$12.37 M
|
| Selling & Marketing
Expenses |
$27.95 M
|
$25.99 M
|
$23.07 M
|
$20.38 M
|
$25.00 M
|
$23.52 M
|
$23.21 M
|
$29.43 M
|
$28.09 M
|
$15.09 M
|
| Selling, General &
Administrative Expenses |
$46.02 M
|
$38.86 M
|
$35.84 M
|
$32.04 M
|
$38.96 M
|
$38.04 M
|
$36.25 M
|
$44.69 M
|
$42.28 M
|
$27.46 M
|
| Other Expenses |
$0.00 |
$2.71 M |
$2.58 M |
$2.68 M |
$2.64 M |
$2.65 M |
$2.68 M |
$2.77 M |
$2.56 M |
$659,000.00 |
| Operating Expenses |
$62.64 M |
$57.79 M |
$52.20 M |
$44.38 M |
$52.59 M |
$51.96 M |
$51.78 M |
$59.84 M |
$59.68 M |
$39.93 M |
| Cost And Expenses |
$82.23 M |
$65.77 M |
$59.23 M |
$51.32 M |
$59.22 M |
$56.64 M |
$55.22 M |
$62.18 M |
$61.44 M |
$41.37 M |
| Interest Income |
$0.00 |
$5.88 M |
$5.41 M |
$5.38 M |
$4.87 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$10.19 M |
$5.88 M |
$5.41 M |
$5.38 M |
$4.87 M |
$4.78 M |
$5.58 M |
$5.18 M |
$4.69 M |
$2.09 M |
| Depreciation &
Amortization |
$8.75 M
|
$2.71 M
|
$2.58 M
|
$2.68 M
|
$2.64 M
|
$2.65 M
|
$2.68 M
|
$2.77 M
|
$2.56 M
|
$659,000.00
|
| EBITDA |
$7.28 M
|
-$8.93 M
|
$2.38 M
|
$2.18 M
|
-$2.63 M
|
-$7.03 M
|
-$13.77 M
|
-$25.08 M
|
-$36.44 M
|
-$32.99 M
|
| EBITDA Ratio |
0.09 |
-0.17 |
0.04 |
0.04 |
-0.05 |
-0.15 |
-0.46 |
-0.73 |
-1.62 |
-3.83 |
| Operating Income Ratio
|
-0.02
|
-0.22
|
-0
|
-0.01
|
-0.1
|
-0.21
|
-0.46
|
-0.81
|
-1.74
|
-3.91
|
| Total Other
Income/Expenses Net |
-$18.12 M
|
-$6.44 M
|
-$3.73 M
|
-$4.91 M
|
-$4.95 M
|
-$6.61 M
|
-$5.39 M
|
-$5.16 M
|
$8.48 M
|
-$2.79 M
|
| Income Before Tax |
-$20.05 M |
-$18.08 M |
-$3.93 M |
-$5.41 M |
-$10.23 M |
-$16.28 M |
-$21.84 M |
-$33.00 M |
-$30.52 M |
-$35.74 M |
| Income Before Tax Ratio
|
-0.25
|
-0.33
|
-0.07
|
-0.11
|
-0.19
|
-0.35
|
-0.61
|
-0.96
|
-1.36
|
-4.24
|
| Income Tax Expense |
$85,000.00 |
$28,000.00 |
$438,000.00 |
-$68,000.00 |
$216,000.00 |
$106,000.00 |
$163,000.00 |
$172,000.00 |
$130,000.00 |
$174,000.00 |
| Net Income |
-$20.13 M |
-$18.11 M |
-$4.37 M |
-$5.34 M |
-$10.44 M |
-$16.38 M |
-$22.00 M |
-$33.17 M |
-$30.65 M |
-$35.91 M |
| Net Income Ratio |
-0.25 |
-0.33 |
-0.07 |
-0.11 |
-0.19 |
-0.35 |
-0.61 |
-0.97 |
-1.37 |
-4.26 |
| EPS |
-0.79 |
-2.59 |
-0.66 |
-1.04 |
-2.19 |
-3.51 |
-4.93 |
-9.42 |
-10.34 |
-13.33 |
| EPS Diluted |
-0.79 |
-2.59 |
-0.66 |
-1.04 |
-2.19 |
-3.47 |
-4.93 |
-9.42 |
-10.34 |
-13.33 |
| Weighted Average Shares
Out |
$25.56 M
|
$7.00 M
|
$6.60 M
|
$5.12 M
|
$4.77 M
|
$4.67 M
|
$4.47 M
|
$3.52 M
|
$2.96 M
|
$2.69 M
|
| Weighted Average Shares
Out Diluted |
$25.56 M
|
$7.00 M
|
$6.60 M
|
$5.12 M
|
$4.77 M
|
$4.72 M
|
$4.47 M
|
$3.52 M
|
$2.96 M
|
$2.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
